International Journal of Endocrinology and Metabolism

Published by: Neoscriber Demo Publisher

The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study

Zahra Bahadoran 1 , Parvin Mirmiran 2 , Sajad Jeddi 3 , Amir Abbas Momenan 4 , Fereidoun Azizi 5 and Asghar Ghasemi 3 , *
Authors Information
1 Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Clinical Nutrition and Diet Therapy, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84775
  • Published Online: October 14, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/ijem.84775

To Cite: Bahadoran Z, Mirmiran P, Jeddi S, Momenan A A, Azizi F, et al. The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84775. doi: 10.5812/ijem.84775.

Abstract
Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Association Between NCDs and Circulating NOx
3. Dietary Intake of NO<sub>3</sub> and NO<sub>2</sub> in Relation to Cardio-Metabolic-Renal Disease
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Ghasemi A, Zahediasl S. Is nitric oxide a hormone? Iran Biomed J. 2011;15(3):59-65. [PubMed: 21987110]. [PubMed Central: PMC3639748].
  • 2. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7(2):156-67. doi: 10.1038/nrd2466. [PubMed: 18167491].
  • 3. Knott AB, Bossy-Wetzel E. Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obes Metab. 2010;12 Suppl 2:126-33. doi: 10.1111/j.1463-1326.2010.01267.x. [PubMed: 21029309]. [PubMed Central: PMC3988980].
  • 4. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008;294(1):F1-9. doi: 10.1152/ajprenal.00424.2007. [PubMed: 17928410].
  • 5. Masha A, Dinatale S, Allasia S, Martina V. Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus. Curr Pharm Biotechnol. 2011;12(9):1354-63. [PubMed: 21235455].
  • 6. Stoclet JC, Muller B, Andriantsitohaina R, Kleschyov A. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry (Mosc). 1998;63(7):826-32. [PubMed: 9721335].
  • 7. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med. 2001;7(10):1138-43. doi: 10.1038/nm1001-1138. [PubMed: 11590438].
  • 8. Hewala TI, Abd El-Moneim NA, Ebied SA, Sheta MI, Soliman K, Abu-Elenean A. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor-alpha, basic fibroblast growth factor and copper as angiogenic markers in premenopausal breast cancer patients: A case-control study. Br J Biomed Sci. 2010;67(4):167-76. doi: 10.1080/09674845.2010.11730315. [PubMed: 21294443].
  • 9. Muto S, Takagi H, Owada Y, Inoue T, Watanabe Y, Yamaura T, et al. Serum nitric oxide as a predictive biomarker for bevacizumab in non-small cell lung cancer patients. Anticancer Res. 2017;37(6):3169-74. doi: 10.21873/anticanres.11676. [PubMed: 28551660].
  • 10. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002;47(6):408-26. [PubMed: 12643001].
  • 11. Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. Jmsr. 2007;2(15):29-32.
  • 12. Ghasemi A, Zahediasl S. Preanalytical and analytical considerations for measuring nitric oxide metabolites in serum or plasma using the Griess method. Clin Lab. 2012;58(7-8):615-24. [PubMed: 22997962].
  • 13. Ghasemi A, Zahediasl S, Azizi F. Elevated nitric oxide metabolites are associated with obesity in women. Arch Iran Med. 2013;16(9):521-5. [PubMed: 23981155].
  • 14. Ghasemi A, Zahedi Asl S, Mehrabi Y, Saadat N, Azizi F. Serum nitric oxide metabolite levels in a general healthy population: Relation to sex and age. Life Sci. 2008;83(9-10):326-31. doi: 10.1016/j.lfs.2008.06.010. [PubMed: 18662705].
  • 15. Ghasemi A, Zahediasl S, Azizi F. Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem. 2010;43(1-2):89-94. doi: 10.1016/j.clinbiochem.2009.09.011. [PubMed: 19782059].
  • 16. Ghasemi A, Zahediasl S, Azizi F. Reference values for serum nitric oxide metabolites in pediatrics. Nitric Oxide. 2010;23(4):264-8. doi: 10.1016/j.niox.2010.07.007. [PubMed: 20667479].
  • 17. Tehrani FR, Behboudi-Gandevani S, Ghasemi A, Azizi F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015;291(1):159-63. doi: 10.1007/s00404-014-3338-x. [PubMed: 25047269].
  • 18. Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F. Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand. 2015;94(7):708-14. doi: 10.1111/aogs.12655. [PubMed: 25867606].
  • 19. Bagheripuor F, Gharibzadeh S, Ghanbari M, Amouzegar A, Tohidi M, Azizi F, et al. Association between serum nitric oxide metabolites and thyroid hormones in a general population: Tehran thyroid study. Endocr Res. 2016;41(3):193-9. doi: 10.3109/07435800.2015.1126844. [PubMed: 26864772].
  • 20. Makhzani P, Afghan M, Tohidi M, Bagheripour F, Azizi F, Ghasemi A. Are serum nitric oxide metabolites associated with fasting insulin among Iranian adults? (Tehran lipid and glucose study). Endocr Res. 2017;42(2):96-101. doi: 10.1080/07435800.2016.1197933. [PubMed: 27356206].
  • 21. Ghasemi A, Syedmoradi L, Momenan AA, Zahediasl S, Azizi F. The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scand J Clin Lab Invest. 2010;70(2):116-21. doi: 10.3109/00365511003611282. [PubMed: 20156035].
  • 22. Mirmiran P, Bahadoran Z, Ghasemi A, Azizi F. The association of dietary l-arginine intake and serum nitric oxide metabolites in adults: A population-based study. Nutrients. 2016;8(5). doi: 10.3390/nu8050311. [PubMed: 27213443]. [PubMed Central: PMC4882723].
  • 23. Bahadoran Z, Ghasemi A, Mirmiran P, Mehrabi Y, Azizi F, Hadaegh F. Estimation and validation of dietary nitrate and nitrite intake in Iranian population. Iran J Public Health. 2018.
  • 24. Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F. Serum nitric oxide metabolites are associated with the risk of hypertriglyceridemic-waist phenotype in women: Tehran lipid and glucose study. Nitric Oxide. 2015;50:52-7. doi: 10.1016/j.niox.2015.08.002. [PubMed: 26284308].
  • 25. Bahadoran ZM, Ghasemi A, Azizi F. The association of serum nitric oxide metabolites and 6-year changes of visceral fat accumulation in adults: Tehran lipid and glucose study. 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). Istanbul, Turkey; 2015.
  • 26. Ghasemi A, Zahediasl S, Azizi F. High serum nitric oxide metabolites and incident metabolic syndrome. Scand J Clin Lab Invest. 2012;72(7):523-30. doi: 10.3109/00365513.2012.701322. [PubMed: 23050497].
  • 27. Bahadoran Z, Mirmiran P, Tahmasebi Nejad Z, Ghasemi A, Azizi F. Serum nitric oxide is associated with the risk of chronic kidney disease in women: Tehran lipid and glucose study. Scand J Clin Lab Invest. 2016;76(4):304-8. doi: 10.3109/00365513.2016.1149880. [PubMed: 26956540].
  • 28. Hadaegh F, Asgari S, Bozorgmanesh M, Jeddi S, Azizi F, Ghasemi A. Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric Oxide. 2016;54:60-6. doi: 10.1016/j.niox.2016.02.004. [PubMed: 26923817].
  • 29. Zahedi Asl S, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008;41(16-17):1342-7. doi: 10.1016/j.clinbiochem.2008.08.076. [PubMed: 18793628].
  • 30. Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F. Association between serum nitric oxide metabolites and hypertension in a general population. Int Angiol. 2011;30(4):380-7. [PubMed: 21747357].
  • 31. Ghasemi A, Zahediasl S, Azizi F. Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur J Epidemiol. 2010;25(1):45-53. doi: 10.1007/s10654-009-9382-3. [PubMed: 19701686].
  • 32. Bahadoran Z, Mirmiran P, Jeddi S, Azizi F, Ghasemi A, Hadaegh F. Nitrate and nitrite content of vegetables, fruits, grains, legumes, dairy products, meats and processed meats. J Food Compos Anal. 2016;51:93-105. doi: 10.1016/j.jfca.2016.06.006.
  • 33. Bahadoran Z, Mirmiran P, Ghasemi A, Carlstrom M, Azizi F, Hadaegh F. Vitamin C intake modify the impact of dietary nitrite on the incidence of type 2 diabetes: A 6-year follow-up in Tehran lipid and glucose study. Nitric Oxide. 2017;62:24-31. doi: 10.1016/j.niox.2016.11.005. [PubMed: 27916563].
  • 34. Bahadoran Z, Mirmiran P, Ghasemi A, Carlstrom M, Azizi F, Hadaegh F. Association between dietary intakes of nitrate and nitrite and the risk of hypertension and chronic kidney disease: Tehran lipid and glucose study. Nutrients. 2016;8(12). doi: 10.3390/nu8120811. [PubMed: 28009811]. [PubMed Central: PMC5188466].
  • 35. Bahadoran Z, Carlstrom M, Ghasemi A, Mirmiran P, Azizi F, Hadaegh F. Total antioxidant capacity of the diet modulates the association between habitual nitrate intake and cardiovascular events: A longitudinal follow-up in Tehran lipid and glucose study. Nutr Metab (Lond). 2018;15:19. doi: 10.1186/s12986-018-0254-2. [PubMed: 29492096]. [PubMed Central: PMC5828061].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments